Novartis (Switzerland) Analysis
| NOVN Stock | CHF 93.68 2.12 2.32% |
Novartis AG is fairly valued with Real Value of 95.26 and Hype Value of 93.68. The main objective of Novartis stock analysis is to determine its intrinsic value, which is an estimate of what Novartis AG is worth, separate from its market price. There are two main types of Novartis' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Novartis' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Novartis' stock to identify patterns and trends that may indicate its future price movements.
The Novartis stock is traded in Switzerland on SIX Swiss Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Switzerland. Novartis is usually not traded on National Day, Christmas Day, St . Stephen 's Day, New Year 's Day, Berchtoldstag, Good Friday, Easter Monday, International Workers ' Day. Novartis Stock trading window is adjusted to Europe/Zurich timezone.
Novartis |
Novartis Stock Analysis Notes
About 34.0% of the company shares are owned by institutional investors. The book value of Novartis was now reported as 28.0. The company last dividend was issued on the 9th of March 2023. Novartis AG had 5:6 split on the 3rd of October 2023. Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. NOVARTIS N operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 108000 people. To find out more about Novartis AG contact the company at 41 61 324 1111 or learn more at https://www.novartis.com.Novartis AG Investment Alerts
| Novartis AG generated a negative expected return over the last 90 days |
Novartis Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 170.42 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novartis's market, we take the total number of its shares issued and multiply it by Novartis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Novartis Profitablity
Novartis' profitability indicators refer to fundamental financial ratios that showcase Novartis' ability to generate income relative to its revenue or operating costs. If, let's say, Novartis is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Novartis' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Novartis' profitability requires more research than a typical breakdown of Novartis' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. Technical Drivers
As of the 25th of November, Novartis secures the Standard Deviation of 0.9676, mean deviation of 0.6811, and Risk Adjusted Performance of (0.08). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novartis AG, as well as the relationship between them. Please verify Novartis AG mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Novartis AG is priced some-what accurately, providing market reflects its recent price of 93.68 per share.Novartis AG Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Novartis middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Novartis AG. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Novartis Outstanding Bonds
Novartis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Novartis AG uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Novartis bonds can be classified according to their maturity, which is the date when Novartis AG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Novartis Predictive Daily Indicators
Novartis intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Novartis stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Novartis Forecast Models
Novartis' time-series forecasting models are one of many Novartis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novartis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Novartis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Novartis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novartis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Novartis. By using and applying Novartis Stock analysis, traders can create a robust methodology for identifying Novartis entry and exit points for their positions.
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. NOVARTIS N operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 108000 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Novartis to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.